Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2011, Article ID 953469, 8 pages
http://dx.doi.org/10.1155/2011/953469
Clinical Study

Oncogenic HPV Types Infection in Adolescents and University Women from North Portugal: From Self-Sampling to Cancer Prevention

1Molecular Oncology Group, Portuguese Institute of Oncology of Porto, Road Dr. António Bernardino Almeida, 4200-072 Porto, Portugal
2CEBIMED, Faculty of Health Sciences, Fernando Pessoa University, 4200-150 Porto, Portugal
3Molecular Virology Laboratory of Virology Service, Portuguese Institute of Oncology of Porto, Road Dr. António Bernardino Almeida, 4200-072 Porto, Portugal
4ICBAS, Abel Salazar Institute for the Biomedical Sciences, University of Porto, 4099-003 Porto, Portugal
5CEQUIMED, Faculty of Pharmacy, University of Porto, 4050-047 Porto, Portugal
6LPCC, Liga Portuguesa Contra O Cancro, Nucleo Regional do Norte, 4200-177 Porto, Portugal

Received 5 September 2011; Accepted 13 October 2011

Academic Editor: Michael Carducci

Copyright © 2011 Jani Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Medeiros, H. Prazeres, D. Pinto et al., “Characterization of HPV genotype profile in squamous cervical lesions in Portugal, a southern European population at high risk of cervical cancer,” European Journal of Cancer Prevention, vol. 14, no. 5, pp. 467–471, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Zur Hausen, “Human papillomaviruses in the pathogenesis of anogenital cancer,” Virology, vol. 184, no. 1, pp. 9–13, 1991. View at Google Scholar · View at Scopus
  3. H. Z. Hausen, “Human papillomavirus & cervical cancer,” Indian Journal of Medical Research, vol. 130, no. 3, p. 209, 2009. View at Google Scholar · View at Scopus
  4. J. B. F. Ferlay, P. Pisani, and D. M. Parkin, Globocan 2002, Cancer Incidence Mortality and Prevalence Worldwide IARC Cancerbase no. 5, version 2.0, IARC Press, Lyon, France, 2004.
  5. P. S. Pinheiro, J. E. Tyczyński, F. Bray, J. Amado, E. Matos, and D. M. Parkin, “Cancer incidence and mortality in Portugal,” European Journal of Cancer, vol. 39, no. 17, pp. 2507–2520, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. B. Moscicki, V. Grubbs Burt, S. Kanowitz, T. Darragh, and S. Shiboski, “The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women,” Cancer, vol. 85, no. 5, pp. 1139–1144, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. C. B. J. Woodman, S. I. Collins, and L. S. Young, “The natural history of cervical HPV infection: unresolved issues,” Nature Reviews Cancer, vol. 7, no. 1, pp. 11–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. zur Hausen, “The search for infectious causes of human cancers: where and why,” Virology, vol. 392, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Salmerón, E. Lazcano-Ponce, A. Lorincz et al., “Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico,” Cancer Causes and Control, vol. 14, no. 6, pp. 505–512, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Schiffman, R. Herrero, A. Hildesheim et al., “HPV DNA testing in cervical cancer screening: results from women in a high risk province of Costa Rica,” Journal of the American Medical Association, vol. 283, no. 1, pp. 87–93, 2000. View at Google Scholar · View at Scopus
  11. L. Kuhn, L. Denny, A. Pollack, A. Lorincz, R. M. Richart, and T. C. Wright, “Human papillomavirus DNA testing for cervical cancer screening in low- resource settings,” Journal of the National Cancer Institute, vol. 92, no. 10, pp. 818–825, 2000. View at Google Scholar · View at Scopus
  12. L. L. Villa, “Prophylactic HPV vaccines: reducing the burden of HPV-related diseases,” Vaccine, vol. 24, no. 1, pp. S1/23–S1/28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Lungu, T. C. Wright, and S. Silverstein, “Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis,” Molecular and Cellular Probes, vol. 6, no. 2, pp. 145–152, 1992. View at Google Scholar · View at Scopus
  14. R. J. Nobre, L. P. de Almeida, and T. C. Martins, “Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm,” Journal of Clinical Virology, vol. 42, no. 1, pp. 13–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Frega, M. Cenci, P. Stentella et al., “Human papillomavirus in virgins and behaviour at risk,” Cancer Letters, vol. 194, no. 1, pp. 21–24, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Frega, P. Stentella, A. De Ioris et al., “Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence,” Cancer Letters, vol. 196, no. 2, pp. 127–134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Petignat, D. L. Faltin, I. Bruchim, M. R. Tramèr, E. L. Franco, and F. Coutlée, “Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis,” Gynecologic Oncology, vol. 105, no. 2, pp. 530–535, 2007. View at Publisher · View at Google Scholar
  18. M. M. Hobbs, B. Van Der Pol, P. Totten et al., “From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections,” Sexually Transmitted Diseases, vol. 35, no. 1, pp. 8–13, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. G. Pretorius and J. L. Belinson, “Letter to the Editor concerning Petignat et al.'s Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007;105(2): 530-535,” Gynecologic Oncology, vol. 107, no. 3, pp. 595–596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. De Roda Husman, J. M. M. Walboomers, A. J. C. Van den Brule, C. J. L. M. Meijer, and P. J. F. Snijders, “The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR,” Journal of General Virology, vol. 76, no. 4, pp. 1057–1062, 1995. View at Google Scholar · View at Scopus
  21. A. Hildesheim, M. H. Schiffman, P. E. Gravitt et al., “Persistence of type-specific human papillomavirus infection among cytologically normal women,” Journal of Infectious Diseases, vol. 169, no. 2, pp. 235–240, 1994. View at Google Scholar · View at Scopus
  22. R. J. Nobre, E. Cruz, O. Real, L. P. De Almeida, and T. C. Martins, “Characterization of common and rare human papillomaviruses in Portuguese women by the polymerase chain reaction, restriction fragment length polymorphism and sequencing,” Journal of Medical Virology, vol. 82, no. 6, pp. 1024–1032, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Muñoz, X. Castellsagué, A. B. de González, and L. Gissmann, “Chapter 1: HPV in the etiology of human cancer,” Vaccine, vol. 24, supplement 3, pp. S1–S10, 2006. View at Publisher · View at Google Scholar
  24. F. Lüdicke, A. Stalberg, P. Vassilakos, A. L. Major, and A. Campana, “High- and intermediate-risk human papillomavirus infection in sexually active adolescent females,” Journal of Pediatric and Adolescent Gynecology, vol. 14, no. 4, pp. 171–174, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. D. A. Bartholomew, “Human papillomavirus infection in adolescents: a rational approach,” Adolescent Medicine Clinics, vol. 15, no. 3, pp. 569–595, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Y. F. Ho, R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk, “Natural history of cervicovaginal papillomavirus infection in young women,” The New England Journal of Medicine, vol. 338, no. 7, pp. 423–428, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. A. B. Moscicki, N. Hills, S. Shiboski et al., “Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females,” Journal of the American Medical Association, vol. 285, no. 23, pp. 2995–3002, 2001. View at Google Scholar · View at Scopus
  28. T. Iftner and L. L. Villa, “Chapter 12: human papillomavirus technologies,” Journal of the National Cancer Institute Monographs, no. 31, pp. 80–88, 2003. View at Google Scholar · View at Scopus
  29. G. S. Ogilvie, D. M. Patrick, M. Schulzer et al., “Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis,” Sexually Transmitted Infections, vol. 81, no. 3, pp. 207–212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Trottier and E. L. Franco, “The epidemiology of genital human papillomavirus infection,” Vaccine, vol. 24, no. 1, pp. S1/4–S1/15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. E. F. Dunne, E. R. Unger, M. Sternberg et al., “Prevalence of HPV infection among females in the United States,” Journal of the American Medical Association, vol. 297, no. 8, pp. 813–819, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. A. B. Moscicki, J. Palefsky, J. Gonzales, and G. K. Schoolnik, “Human papillomavirus infection in sexually active adolescent females: prevalence and risk factors,” Pediatric Research, vol. 28, no. 5, pp. 507–513, 1990. View at Google Scholar · View at Scopus
  33. R. L. Winer, S. K. Lee, J. P. Hughes, D. E. Adam, N. B. Kiviat, and L. A. Koutsky, “Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students,” American Journal of Epidemiology, vol. 157, no. 3, pp. 218–226, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Ammatuna, L. Giovannelli, D. Matranga, S. Ciriminna, and A. Perino, “Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, south Italy,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 8, pp. 2002–2006, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. C. B. J. Woodman, S. Collins, H. Winter et al., “Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study,” The Lancet, vol. 357, no. 9271, pp. 1831–1836, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. J. P. Figueroa, E. Ward, T. E. Luthi, S. H. Vermund, A. R. Brathwaite, and R. D. Burk, “Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity,” Sexually Transmitted Diseases, vol. 22, no. 2, pp. 114–118, 1995. View at Google Scholar · View at Scopus
  37. R. D. Burk, G. Y. F. Ho, L. Beardsley, M. Lempa, M. Peters, and R. Bierman, “Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women,” Journal of Infectious Diseases, vol. 174, no. 4, pp. 679–689, 1996. View at Google Scholar · View at Scopus
  38. K. L. Kotloff, S. S. Wasserman, K. Russ et al., “Detection of genital human papillomavirus and associated cytological abnormalities among college women,” Sexually Transmitted Diseases, vol. 25, no. 5, pp. 243–250, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. M. F. Janicek and H. E. Averette, “Cervical cancer: prevention, diagnosis, and therapeutics,” Ca-A Cancer Journal for Clinicians, vol. 51, no. 2, pp. 92–114, 2001. View at Google Scholar · View at Scopus
  40. S. de Sanjosé, M. Diaz, X. Castellsagué et al., “Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis,” Lancet Infectious Diseases, vol. 7, no. 7, pp. 453–459, 2007. View at Publisher · View at Google Scholar
  41. P. E. Gravitt, C. L. Peyton, T. Q. Alessi et al., “Improved amplification of genital human papillomaviruses,” Journal of Clinical Microbiology, vol. 38, no. 1, pp. 357–361, 2000. View at Google Scholar · View at Scopus
  42. A. R. Giuliano, R. Harris, R. L. Sedjo et al., “Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study,” Journal of Infectious Diseases, vol. 186, no. 4, pp. 462–469, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. L. H. S. Oliveira, M. D. P. L. Ferreira, E. F. Augusto et al., “Human papillomavirus genotypes in asymptomatic young women from public schools in Rio de Janeiro, Brazil,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 43, no. 1, pp. 4–8, 2010. View at Google Scholar · View at Scopus
  44. J. A. N. Gibson, P. Bayrak-Toydemir, P. Cotter et al., “The association for molecular pathology's approach to supporting a global agenda to embrace personalized genomic medicine,” Journal of Molecular Diagnostics, vol. 13, pp. 249–251, 2011. View at Google Scholar
  45. M. Ladanyi and P. C. W. Hogendoorn, “Cancer biology and genomics: translating discoveries, transforming pathology,” Journal of Pathology, vol. 223, no. 2, pp. 99–101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. M. E. Sobel, A. Bagg, A. M. Caliendo, M. Ladanyi, and B. Zehnbauer, “The evolution of molecular genetic pathology: advancing 20th-century diagnostic methods into potent tools for the new millennium,” Journal of Molecular Diagnostics, vol. 10, no. 6, pp. 480–483, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. D. L. Evers, C. B. Fowler, B. R. Cunningham, J. T. Mason, and T. J. O'Leary, “The effect of formaldehyde fixation on rna: optimization of formaldehyde adduct removal,” Journal of Molecular Diagnostics, vol. 13, no. 3, pp. 282–288, 2011. View at Google Scholar
  48. E. L. Franco, “A new generation of studies of human papillomavirus DNA testing in cervical cancer screening,” Journal of the National Cancer Institute, vol. 101, no. 23, pp. 1600–1601, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. E. L. Franco and J. Cuzick, “Cervical cancer screening following prophylactic human papillomavirus vaccination,” Vaccine, vol. 26, no. 1, pp. A16–A23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. H. van Monsjou, M. van Velthuysen, M. van den Brekel, E. Jordanova, C. Melief, and A. Balm, “Hpv status in young hnscc patients,” International Journal of Cancer. In press.
  51. C. C. Black, H. A. Bentley, T. H. Davis, and G. J. Tsongalis, “Use of a linear array for the detection of human papillomavirus genotypes in head and neck cancer,” Archives of Pathology and Laboratory Medicine, vol. 134, no. 12, pp. 1813–1817, 2010. View at Google Scholar · View at Scopus
  52. M. Gillison, “HPV and its effect on head and neck cancer prognosis,” Clinical Advances in Hematology and Oncology, vol. 8, no. 10, pp. 680–682, 2010. View at Google Scholar · View at Scopus
  53. L. F. Salazar, R. A. Crosby, R. J. DiClemente et al., “African-American female adolescents who engage in oral, vaginal and anal sex: "Doing it all" as a significant marker for risk of sexually transmitted infection,” AIDS and Behavior, vol. 13, no. 1, pp. 85–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Tota, S. M. Mahmud, A. Ferenczy, F. Coutĺe, and E. L. Franco, “Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era,” Sexual Health, vol. 7, no. 3, pp. 376–382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. J. L. Myers, “Why do young women get tested for sexually transmitted infections? Evidence from the national longitudinal study of adolescent health,” Journal of Women's Health, vol. 20, no. 8, pp. 1225–1231, 2011. View at Publisher · View at Google Scholar
  56. R. Medeiros and D. Ramada, “Knowledge differences between male and female university students about human papillomavirus (HPV) and cervical cancer: implications for health strategies and vaccination,” Vaccine, vol. 29, no. 2, pp. 153–160, 2010. View at Publisher · View at Google Scholar · View at Scopus